Endometrial cancer patients’ preferences for follow-up after treatment: A cross-sectional survey

Kinta Beaver, Susan Williamson, Chris J. Sutton, Anne Gardner, Pierre Martin-hirsch

Research output: Contribution to journalArticlepeer-review

30 Downloads (Pure)

Abstract

PurposeAlternatives to hospital follow-up (HFU) following treatment for cancer have been advocated. Telephone follow-up (TFU) and patient-initiated follow-up are being implemented but it is unclear if these approaches will meet the preferences and needs of patients. This study aimed to explore the preferences of endometrial cancer patients and their levels of satisfaction with HFU and nurse-led TFU.MethodsA cross-sectional survey design was utilised and a questionnaire was administered to 236 patients who had participated in a randomised controlled trial comparing HFU with TFU for women diagnosed with Stage I endometrial cancer (ENDCAT trial).Results211 (89.4%) patients returned the questionnaire; 105 in the TFU group and 106 in the HFU group. The TFU group were more likely to indicate that appointments were on time (p < 0.001) and were more likely to report that their appointments were thorough (p = 0.011). Participants tended to prefer what was familiar to them. Those in the HFU group tended to prefer hospital-based appointments while the TFU group tended to prefer appointments with a clinical nurse specialist, regardless of locality.ConclusionsTo provide patient centred follow-up services we need to ensure that patient preferences are taken into account and understand that patients may come to prefer what they have experienced. Patient initiated approaches may become standard and preferred practice but TFU remains a high-quality alternative to HFU and may provide an effective transition between HFU and patient-initiated approaches.
Original languageEnglish
Pages (from-to)101722
JournalEuropean Journal of Oncology Nursing
Early online date24 Jan 2020
DOIs
Publication statusPublished - 2020

Fingerprint

Dive into the research topics of 'Endometrial cancer patients’ preferences for follow-up after treatment: A cross-sectional survey'. Together they form a unique fingerprint.

Cite this